us 5298520 crystal form of rizatriptan

Description
S. Patent No. 5 298 520 NOTICE OF FINAL DETERMINATION A determination has been made that U.S. Patent No. 5 298 520 which claims the human drug product Maxalt rizatriptan benzoate and its method ofuse is eligible for patent term extension under 35 U.S.C. Upon issuance of the certificate of extension the following information will be published in the Official Gazette Patent No Granted Original Expiration Date...
Fill & Sign Online, Print, Email, Fax, or Download
Fill Online
  • Fill Online
  • eSign
  • eFax
  • Email
  • Add Annotations
  • Share
us 5298520 crystal form of rizatriptan
Rate This Form

4.0

Satisfied

31

 Votes